BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
Authors found that BMI of ≥27 shows excellent diagnostic performance
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
Reduction seen in risk for clinically important kidney outcomes and death from cardiovascular causes
Weight Navigation Program Boosts Use of Weight Management Treatments
Greater use of weight management treatments seen with WNP, including bariatric surgery, low-calorie meal replacement
HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors
In a recent study, donors had initial drop in eGFR after nephrectomy, followed by lesser decline per year than nondonors
Delay in Hospital Arrival After Stroke Linked to Social Vulnerability
Areas with high incidence of delay characterized by increased social vulnerability including SES, housing type, and transportation
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending
From 2007 to 2019, medical burden increased from 23.5 to 26.4 percent for low-income families and from 5.4 to 6.5 percent for higher-income families
Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium
Findings seen for men and women even at high volumes of aerobic leisure-time physical activity
Physical Activity Time, Step Counts Yield Similar Results
Similar benefits seen for all-cause mortality and cardiovascular disease prevention
Social Determinants of Health Explain Disparities in Treatment-Resistant Hypertension
Findings seen for excess treatment-resistant hypertension among Black U.S. adults
Semaglutide Has Lasting Benefit for Weight Loss
Second study shows cardiovascular benefit for semaglutide, regardless of weight loss
